Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Novartis wins CHMP nod for drug combo against some lung cancers

      Novartis wins CHMP nod for drug combo against some lung cancers

      supriya kashyap kashyap26 Feb 2017 10:43 AM IST
      Swiss drugmaker Novartis's drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer after a...
      Zydus Cadila to launch seasonal flu vaccine in India

      Zydus Cadila to launch seasonal flu vaccine in India

      supriya kashyap kashyap26 Feb 2017 10:42 AM IST
      New Delhi : Zydus Cadila has received regulatory approvals to launch tetravalent inactivated influenza vaccine for seasonal flu in India.The company...
      Sequoia Fund wins dismissal of lawsuit over huge Valeant stake

      Sequoia Fund wins dismissal of lawsuit over huge Valeant stake

      supriya kashyap kashyap26 Feb 2017 10:42 AM IST
      New York : A New York state judge has dismissed a lawsuit accusing the Sequoia Fund, known for its ties to Warren Buffett, of recklessly making a...
      Cempras bacterial skin infection drug clears study, shares surge

      Cempra's bacterial skin infection drug clears study, shares surge

      supriya kashyap kashyap25 Feb 2017 6:30 PM IST
      Cempra Inc said that its experimental oral drug to treat acute bacterial skin infections cleared a late-stage study, bringing the antibiotic developer...
      FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

      FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results

      supriya kashyap kashyap25 Feb 2017 11:40 AM IST
      The U.S. Food and Drug Administration allowed marketing of the PhenoTest BC Kit, performed on the Pheno System. This is the first test to identify...
      You cannot hang on to breast cancer drug: Delhi HC to Roche

      You cannot hang on to breast cancer drug: Delhi HC to Roche

      supriya kashyap kashyap25 Feb 2017 10:37 AM IST
      New Delhi : The Delhi High Court told Swiss pharma major Roche that it "cannot hang on to" breast cancer drug Trastuzumab, innovated by it, for the...
      AYUSH ministry invites global drug makers to set up plants in India

      AYUSH ministry invites global drug makers to set up plants in India

      supriya kashyap kashyap25 Feb 2017 10:36 AM IST
      New Delhi : AYUSH Minister Shripad Yesso Naik invited drug manufacturers from across the world to set up their plants in the country under the 'Make...
      Zydus gets USFDA nod for phase II trials of liver drug

      Zydus gets USFDA nod for phase II trials of liver drug

      supriya kashyap kashyap24 Feb 2017 11:32 AM IST
      New Delhi : Drug firm Zydus Cadila said the US health regulator has approved the group's plans to initiate phase II clinical trials of Saroglitazar...
      China updates key drug list in boost for pharma

      China updates key drug list in boost for pharma

      supriya kashyap kashyap24 Feb 2017 11:26 AM IST
      Shanghai : China has updated a key list of medicines covered by basic medical insurance schemes, the Ministry of Human Resources and Social Security...
      Dr Reddy’s Miryalaguda Plant Gets Three Observations From US Regulator

      Dr Reddy’s Miryalaguda Plant Gets Three Observations From US Regulator

      supriya kashyap kashyap23 Feb 2017 10:45 AM IST
      Hyderabad : Dr Reddy’s Laboratories Ltd. has received three observations from the U.S. Food and Drug Administration (FDA) after the regulator...
      Manipal Group, CDC Group join hands for healthcare services

      Manipal Group, CDC Group join hands for healthcare services

      supriya kashyap kashyap23 Feb 2017 10:33 AM IST
      Mumbai : Manipal Education and Medical Group (MEMG) announced partnership with CDC Group Plc, the UK’s Development Finance Institution to invest an...
      Aurobindo recalls 47,000 bottles of antidepressant capsules in US

      Aurobindo recalls 47,000 bottles of antidepressant capsules in US

      supriya kashyap kashyap23 Feb 2017 10:27 AM IST
      New Delhi : The US arm of Aurobindo Pharma is recalling 47,040 bottles of Venlafaxine Hydrochloride extended release capsules, manufactured by the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok